Kingworld Medicines Group Limited (HKG:1110)

Kingworld Medicines Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	312	270	392	529	473	467
Market Cap Growth	-8.77%	-31.19%	-25.88%	11.84%	1.33%	-14.77%
Enterprise Value	600	465	522	655	601	686
Last Close Price	0.53	0.43	0.56	0.74	0.62	0.61
PE Ratio	50.58	6.10	9.34	20.58	12.71	33.56
Forward PE	-	17.33	17.33	17.33	17.33	17.33
PS Ratio	0.30	0.24	0.33	0.49	0.46	0.53
PB Ratio	0.41	0.36	0.51	0.67	0.54	0.58
P/TBV Ratio	0.54	0.46	0.67	0.89	0.75	0.83
P/FCF Ratio	-	2.68	-	5.03	16.85	3.46
P/OCF Ratio	-	1.87	8.42	2.51	4.75	3.18
EV/Sales Ratio	0.58	0.41	0.44	0.61	0.58	0.78
EV/EBITDA Ratio	7.13	4.18	5.35	5.39	5.08	6.41
EV/EBIT Ratio	8.37	4.69	6.02	7.21	6.87	8.77
EV/FCF Ratio	-	4.61	-	6.22	21.40	5.08
Debt / Equity Ratio	0.62	0.57	0.51	0.42	0.33	0.45
Debt / EBITDA Ratio	7.42	3.55	3.59	2.45	2.25	3.05
Debt / FCF Ratio	-	4.25	-	3.12	10.44	2.69
Asset Turnover	0.65	0.77	0.83	0.77	0.69	0.59
Inventory Turnover	6.10	6.65	7.89	7.10	4.93	2.78
Quick Ratio	0.87	0.87	0.92	0.90	1.00	1.00
Current Ratio	1.14	1.18	1.27	1.15	1.35	1.29
Return on Equity (ROE)	5.53%	10.60%	8.84%	6.16%	7.32%	7.53%
Return on Assets (ROA)	2.02%	4.23%	3.78%	4.05%	3.61%	3.25%
Return on Capital (ROIC)	2.59%	5.39%	4.82%	5.17%	4.58%	4.36%
Return on Capital Employed (ROCE)	5.30%	10.30%	9.00%	11.10%	9.60%	9.40%
Earnings Yield	1.90%	16.39%	10.70%	4.86%	7.87%	2.98%
FCF Yield	-	37.36%	-17.77%	19.88%	5.94%	28.91%
Dividend Yield	5.98%	7.36%	6.02%	3.35%	3.84%	1.07%
Payout Ratio	-	47.60%	36.54%	58.45%	10.89%	104.76%
Buyback Yield / Dilution	3.99%	2.66%	2.49%	-0.04%	1.29%	1.00%
Total Shareholder Return	9.97%	10.02%	8.51%	3.32%	5.12%	2.07%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.